Cargando…
Could digital patient communities be the launch pad for patient-centric trial design?
The system of medical discovery does not revolve around patients as unique individuals with preferences, needs, and desires. Rather it revolves around scientific scrutiny, the needs of the sponsor, and the desires for regulatory approval. The patient is only a subject. Is it any wonder, then, that s...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039333/ https://www.ncbi.nlm.nih.gov/pubmed/24885434 http://dx.doi.org/10.1186/1745-6215-15-172 |
| _version_ | 1782318472003321856 |
|---|---|
| author | Wicks, Paul |
| author_facet | Wicks, Paul |
| author_sort | Wicks, Paul |
| collection | PubMed |
| description | The system of medical discovery does not revolve around patients as unique individuals with preferences, needs, and desires. Rather it revolves around scientific scrutiny, the needs of the sponsor, and the desires for regulatory approval. The patient is only a subject. Is it any wonder, then, that some patients have rejected the current medical paradigm and sought to find their own path? |
| format | Online Article Text |
| id | pubmed-4039333 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40393332014-05-31 Could digital patient communities be the launch pad for patient-centric trial design? Wicks, Paul Trials Commentary The system of medical discovery does not revolve around patients as unique individuals with preferences, needs, and desires. Rather it revolves around scientific scrutiny, the needs of the sponsor, and the desires for regulatory approval. The patient is only a subject. Is it any wonder, then, that some patients have rejected the current medical paradigm and sought to find their own path? BioMed Central 2014-05-15 /pmc/articles/PMC4039333/ /pubmed/24885434 http://dx.doi.org/10.1186/1745-6215-15-172 Text en Copyright © 2014 Wicks; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Commentary Wicks, Paul Could digital patient communities be the launch pad for patient-centric trial design? |
| title | Could digital patient communities be the launch pad for patient-centric trial design? |
| title_full | Could digital patient communities be the launch pad for patient-centric trial design? |
| title_fullStr | Could digital patient communities be the launch pad for patient-centric trial design? |
| title_full_unstemmed | Could digital patient communities be the launch pad for patient-centric trial design? |
| title_short | Could digital patient communities be the launch pad for patient-centric trial design? |
| title_sort | could digital patient communities be the launch pad for patient-centric trial design? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039333/ https://www.ncbi.nlm.nih.gov/pubmed/24885434 http://dx.doi.org/10.1186/1745-6215-15-172 |
| work_keys_str_mv | AT wickspaul coulddigitalpatientcommunitiesbethelaunchpadforpatientcentrictrialdesign |